BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

2829 related articles for article (PubMed ID: 9987495)

  • 21. Neoadjuvant therapy for resectable pancreatic cancer.
    Raut CP; Evans DB; Crane CH; Pisters PW; Wolff RA
    Surg Oncol Clin N Am; 2004 Oct; 13(4):639-61, ix. PubMed ID: 15350939
    [TBL] [Abstract][Full Text] [Related]  

  • 22. An evidence-based approach to the surgical management of resectable pancreatic adenocarcinoma.
    Stojadinovic A; Brooks A; Hoos A; Jaques DP; Conlon KC; Brennan MF
    J Am Coll Surg; 2003 Jun; 196(6):954-64. PubMed ID: 12788434
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Efficacy of current adjuvant and neoadjuvant therapeutic concepts in gastric cancer?].
    Kretzschmar A; Schlag PM
    Zentralbl Chir; 2006 Apr; 131(2):121-5. PubMed ID: 16612778
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Surgical resection after radiochemotherapy in patients with unresectable adenocarcinoma of the pancreas.
    Sa Cunha A; Rault A; Laurent C; Adhoute X; Vendrely V; Béllannée G; Brunet R; Collet D; Masson B
    J Am Coll Surg; 2005 Sep; 201(3):359-65. PubMed ID: 16125068
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Comparison of neoadjuvant cisplatin-based chemotherapy versus radiochemotherapy followed by resection for stage III (N2) NSCLC.
    Pezzetta E; Stupp R; Zouhair A; Guillou L; Taffé P; von Briel C; Krueger T; Ris HB
    Eur J Cardiothorac Surg; 2005 Jun; 27(6):1092-8. PubMed ID: 15896624
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The 'Sentinel Node' Concept: More Questions Raised than Answers Provided?
    Schlag PM
    Oncologist; 1998; 3(5):VI-VII. PubMed ID: 10388128
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Simultaneous radiochemotherapy in cervical cancer: recommendations for chemotherapy.
    Dunst J; Haensgen G
    Strahlenther Onkol; 2001 Dec; 177(12):635-40. PubMed ID: 11789401
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Standards, options and recommendations: concomitant radiochemotherapy for cancer of the cervix: a critical analysis of the literature and update of SOR].
    Haie-Meder C; Fervers B; Chauvergne J; Fondrinier E; Lhommé C; Guastalla JP; Resbeut M
    Bull Cancer; 1999 Oct; 86(10):829-41. PubMed ID: 10572234
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Adenocarcinoma of the head of the pancreas: effects of surgical and nonsurgical therapy on survival--a ten-year experience.
    Carr JA; Ajlouni M; Wollner I; Wong D; Velanovich V
    Am Surg; 1999 Dec; 65(12):1143-9. PubMed ID: 10597062
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Utilization of multimodal therapy concepts in stomach carcinoma in Germany].
    Bösing NM; Heise JW; Röher HD
    Zentralbl Chir; 2000; 125(4):341-7. PubMed ID: 10829314
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The case for routine use of adjuvant therapy in pancreatic cancer.
    Kennedy EP; Yeo CJ
    J Surg Oncol; 2007 Jun; 95(7):597-603. PubMed ID: 17230543
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Radiotherapy in the adjuvant management of pancreatic adenocarcinoma.
    Abrams RA
    Semin Oncol; 2005 Dec; 32(6 Suppl 9):S30-2. PubMed ID: 16399427
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Combination radiotherapy and chemotherapy in cancer of the pancreas. Review of the literature and prospects].
    Reboul F; Serin D; Martin D; Plat F
    Bull Cancer; 1990; 77(3):275-81. PubMed ID: 2187546
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Conclusions from the European Study Group for Pancreatic Cancer adjuvant trial of chemoradiotherapy and chemotherapy for pancreatic cancer.
    Ghaneh P; Neoptolemos JP
    Surg Oncol Clin N Am; 2004 Oct; 13(4):567-87, vii-viii. PubMed ID: 15350935
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Adjuvant chemoradiotherapy in pancreatic adenocarcinoma.
    Thomas PR
    Hepatogastroenterology; 1998; 45(21):610-2. PubMed ID: 9684105
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Adjuvant postoperative radiation therapy +/- 5-FU in resected carcinoma of the pancreas.
    Foo ML; Gunderson LL
    Hepatogastroenterology; 1998; 45(21):613-23. PubMed ID: 9684106
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Adjuvant and neoadjuvant treatment for pancreatic adenocarcinoma in 2006].
    Deberne M; Huguet F; Le Scodan R; Hammel P; Andre T
    Bull Cancer; 2007 Jan; 94(1):72-80. PubMed ID: 17237007
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Preoperative versus postoperative chemoradiation for patients with resected pancreatic adenocarcinoma.
    Pendurthi TK; Hoffman JP; Ross E; Johnson DE; Eisenberg BL
    Am Surg; 1998 Jul; 64(7):686-92. PubMed ID: 9655283
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Possibilities and limits of cytostatic chemotherapy in pancreatic carcinoma].
    Scheithauer W
    Wien Klin Wochenschr; 1994; 106(22):704-8. PubMed ID: 7825320
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Survival effects of adjuvant chemoradiotherapy after resection for pancreatic carcinoma.
    Yang R; Cheung MC; Byrne MM; Jin X; Montero AJ; Jones C; Koniaris LG
    Arch Surg; 2010 Jan; 145(1):49-56. PubMed ID: 20083754
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 142.